Skip to main content

Main menu

  • Home
  • Current Issue
  • Content
    • Current Issue
    • Early Access
    • Multimedia
    • Podcast
    • Collections
    • Past Issues
    • Articles by Subject
    • Articles by Type
    • Supplements
    • Plain Language Summaries
    • Calls for Papers
  • Info for
    • Authors
    • Reviewers
    • Job Seekers
    • Media
  • About
    • Annals of Family Medicine
    • Editorial Staff & Boards
    • Sponsoring Organizations
    • Copyrights & Permissions
    • Announcements
  • Engage
    • Engage
    • e-Letters (Comments)
    • Subscribe
    • Podcast
    • E-mail Alerts
    • Journal Club
    • RSS
    • Annals Forum (Archive)
  • Contact
    • Contact Us
  • Careers

User menu

  • My alerts

Search

  • Advanced search
Annals of Family Medicine
  • My alerts
Annals of Family Medicine

Advanced Search

  • Home
  • Current Issue
  • Content
    • Current Issue
    • Early Access
    • Multimedia
    • Podcast
    • Collections
    • Past Issues
    • Articles by Subject
    • Articles by Type
    • Supplements
    • Plain Language Summaries
    • Calls for Papers
  • Info for
    • Authors
    • Reviewers
    • Job Seekers
    • Media
  • About
    • Annals of Family Medicine
    • Editorial Staff & Boards
    • Sponsoring Organizations
    • Copyrights & Permissions
    • Announcements
  • Engage
    • Engage
    • e-Letters (Comments)
    • Subscribe
    • Podcast
    • E-mail Alerts
    • Journal Club
    • RSS
    • Annals Forum (Archive)
  • Contact
    • Contact Us
  • Careers
  • Follow annalsfm on Twitter
  • Visit annalsfm on Facebook
Research ArticleOriginal Research

Identifying Adverse Drug Events in Older Community-Dwelling Patients

Caitriona Cahir, Emma Wallace, Anthony Cummins, Conor Teljeur, Catherine Byrne, Kathleen Bennett and Tom Fahey
The Annals of Family Medicine March 2019, 17 (2) 133-140; DOI: https://doi.org/10.1370/afm.2359
Caitriona Cahir
1Division of Population Health Sciences, Royal College of Surgeons in Ireland, Dublin, Ireland
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: caitrionacahir@rcsi.ie
Emma Wallace
2HRB Centre for Primary Care Research, Department of General Practice, Royal College of Surgeons in Ireland, Dublin, Ireland
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anthony Cummins
3Perdana University-Royal College of Surgeons in Ireland, Selangor, Malaysia
MRCGP
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Conor Teljeur
4Health Information and Quality Authority, George’s Court, Dublin, Ireland
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Catherine Byrne
1Division of Population Health Sciences, Royal College of Surgeons in Ireland, Dublin, Ireland
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kathleen Bennett
1Division of Population Health Sciences, Royal College of Surgeons in Ireland, Dublin, Ireland
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tom Fahey
2HRB Centre for Primary Care Research, Department of General Practice, Royal College of Surgeons in Ireland, Dublin, Ireland
MD, FRCGP
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • eLetters
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Tables

  • Additional Files
    • View popup
    Table 1

    Performance Characteristics of the Self-Report ADE Measure (N = 859 Patients)

    Estimated Value95% CI
    Sensitivity29%27%-31%
    Specificity93%92%-94%
    PPV57%54%-60%
    NPV81%80%-81%
    LR+4.223.78-4.72
    LR–0.760.74-0.78
    • ADE = adverse drug effect; LR+ = positive likelihood ratio; LR− = negative likelihood ratio; NPV = negative predictive value; PPV = positive predictive value.

    • Note: Based on the number of patients with an ADE (reported symptom established as an ADE, true and false positive and true and false negative).

    • View popup
    Table 2

    Attributes of the More Prevalent Patient-Reported ADEs

    ADEaPatients Self-Reporting ADE, No. (%)Main Therapeutic Drug Group Associated With ADENo. (%) of Therapeutic Drug Group With ADEbSeverityBothered, No. (%)Reported to Physician, No. (%)Sensitivity, %Specificity, %
    Bruise easily266 (31)Antithrombotic agents (eg, aspirin, warfarin)249 (49)Mild55 (21)74 (28)5390
    Difficulty stopping a small cut from bleeding101 (12)Antithrombotic agents (eg, aspirin, warfarin)97 (19)Mild26 (26)22 (22)7372
    Up at night to urinate153 (18)Diuretics (eg, furosemide, bendroflumethiazide)147 (44)Mild43 (28)33 (22)1895
    Dizziness or lightheadedness117 (14)Diuretics (eg, furosemide, bendroflumethiazide)19 (6)Mild71 (61)73 (62)2884
    Beta-blocking agents (eg, bisoprolol, atenolol, metoprolol)32 (13)
    Analgesics (eg, codeine combinations, tramadol, buprenorphine, oxycodone)32 (31)
    Psychoanaleptics (eg, amitriptyline, doxepin)10 (15)
    Psycholeptics (eg, benzodiazepine derivatives, trifluoperazine)15 (31)
    Unsteadiness while standing75 (9)Analgesics (eg, codeine combinations, tramadol, buprenorphine, oxycodone)28 (27)Mild39 (52)33 (44)4100
    Psychoanaleptics (eg, amitriptyline, doxepin)10 (15)
    Psycholeptics (eg, benzodiazepine derivatives, trifluoperazine)20 (42)
    Constipation137 (16)Calcium channel blockers (eg, amlodipine, lercanidipine, diltiazem)28 (21)Mild69 (50)73 (53)2289
    Analgesics (eg, codeine combinations, tramadol, buprenorphine, oxycodone)40 (39)
    Psychoanaleptics (eg, amitriptyline, doxepin)11 (17)
    Indigestion or heartburn115 (13)Antithrombotic agents (eg, aspirin, warfarin)92 (18)Mild38 (33)57 (50)1289
    Anti-inflammatory and antirheumatic products (eg, diclofenac, ibuprofen, etoricoxib)23 (32)
    Fatigue or unusual tiredness87 (10)Beta-blocking agents (eg, bisoprolol, atenolol, metoprolol)38 (15)Mild43 (49)24 (28)1792
    Analgesics (eg, codeine combinations, tramadol, buprenorphine, oxycodone)30 (29)
    Dry mouth84 (10)Diuretics (eg, furosemide, bendroflumethiazide)50 (15)Mild28 (33)17 (20)3377
    Psychoanaleptics (eg, amitriptyline, doxepin)12 (18)
    Ankle swelling68 (8)Calcium channel blockers (eg, amlodipine, lercanidipine, diltiazem)68 (52)Mild25 (37)44 (65)2790
    Cough66 (8)Agents acting on the renin-angiotensin system (eg, ramipril, perindopril, lisinopril)62 (52)Mild35 (53)37 (56)1890
    Muscle pain or weakness57 (7)Serum lipid–reducing agents (eg, atorvastatin, pravastatin, rosuvastatin, simvastatin)48 (43)Mild43 (75)27 (47)1896
    • ADE = adverse drug effect.

    • ↵a ADE is a patient-reported symptom that was established as an ADE per independent clinician review.

    • b The proportion of patients with an ADE to this therapeutic drug group as a percentage of the overall number of patients prescribed medication from this therapeutic group during the study period.

    • View popup
    Table 3

    Description of the Most Common ADEs Leading to Hospitalization (N = 859 Patients)

    Physiologic SystemADEaMain Therapeutic Drug Group Associated With ADESeverity RatingHospital A&E (n = 32), No. (%)Hospital Outpatient (n = 26), No. (%)
    Central nervous systemDizziness/unsteadiness on feet/fallsBeta-blocking agents, diuretics, psychoanaleptics, psycholeptics, analgesicsModerate13 (41)3 (12)
    GastrointestinalPain in abdomen, diarrheaAnti-inflammatory and antirheumatic products, proton-pump inhibitorsMild11 (34)8 (31)
    CardiovascularFaintingBeta-blocking agents, diureticsModerate3 (9)1 (4)
    GenitourinaryUp at night to urinate, urinating more or less oftenDiureticsMild2 (6)5 (19)
    MusculoskeletalMuscle pain or weaknessSerum lipid–reducing agentsMild03 (12)
    • A&E = accident & emergency department; ADE = adverse drug effect.

    • ↵a ADE is a patient-reported symptom that was established as an ADE per independent clinician review.

Additional Files

  • Tables
  • The Article in Brief

    Identifying Adverse Drug Events in Older Community-Dwelling Patients

    Caitriona Cahir , and colleagues

    Background Patient reporting of suspected adverse drug events could increase knowledge about the safety of medication and provide important information to healthcare professionals. This study evaluates a patient-reported instrument for identifying adverse drug events in older adults with multiple medical conditions in the community setting

    What This Study Found Older adults often do not recognize a medical symptom as an adverse effect of their medication. In the study, patients 70 years of age or older were asked if they had experienced a list of 74 symptoms in the previous six months and if, (1) they believed the symptom was related to their medication; (2) the symptom had bothered them; (3) they had discussed it with their family physician, and (4) they required hospital care due to the symptom. Self-reported symptoms were independently reviewed by two clinicians who determined the likelihood that the symptom was an adverse drug event. Family physician medical records were also reviewed for any report of an adverse drug event. Among 859 participating patients, 674 (78 percent) were classified as having at least one adverse drug event during the study period. Antithrombotic drugs (intended to reduce the formation of blood clots) were most frequently associated with adverse drug events, with 86 percent of patients prescribed aspirin and warfarin reporting bruising, bleeding, and indigestion. Patients were most bothered by muscle pain and weakness (75 percent), dizziness or lightheadedness (61 percent), and unsteadiness on their feet (52 percent) but did not associate these symptoms with their medication. Patients were less bothered by more prevalent adverse drug events; only 21 percent were bothered by minor hemorrhages from antithrombotic therapy. On average, patients reported 39 percent of adverse drug events to their family physician. Patients who did not do so felt the symptoms were the result of old age and did not want to bother their doctors.

    Implications

    • The authors call for health information technology and patient outreach programs to manage and track medication symptoms and help patients monitor their medications.
PreviousNext
Back to top

In this issue

The Annals of Family Medicine: 17 (2)
The Annals of Family Medicine: 17 (2)
Vol. 17, Issue 2
March/April 2019
  • Table of Contents
  • Index by author
  • Back Matter (PDF)
  • In Brief
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Annals of Family Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Identifying Adverse Drug Events in Older Community-Dwelling Patients
(Your Name) has sent you a message from Annals of Family Medicine
(Your Name) thought you would like to see the Annals of Family Medicine web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
5 + 1 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Identifying Adverse Drug Events in Older Community-Dwelling Patients
Caitriona Cahir, Emma Wallace, Anthony Cummins, Conor Teljeur, Catherine Byrne, Kathleen Bennett, Tom Fahey
The Annals of Family Medicine Mar 2019, 17 (2) 133-140; DOI: 10.1370/afm.2359

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Get Permissions
Share
Identifying Adverse Drug Events in Older Community-Dwelling Patients
Caitriona Cahir, Emma Wallace, Anthony Cummins, Conor Teljeur, Catherine Byrne, Kathleen Bennett, Tom Fahey
The Annals of Family Medicine Mar 2019, 17 (2) 133-140; DOI: 10.1370/afm.2359
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • INTRODUCTION
    • METHODS
    • RESULTS
    • DISCUSSION
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • eLetters
  • Info & Metrics
  • PDF

Related Articles

  • PubMed
  • Google Scholar

Cited By...

  • Challenges and barriers to physician decision-making for prescribing and deprescribing among patients with multimorbidity in eastern Chinas primary care settings: a qualitative study
  • Adverse drug reactions and associated patient characteristics in older community-dwelling adults: a 6-year prospective cohort study
  • In This Issue: Minding the Gaps
  • Google Scholar

More in this TOC Section

  • Teamwork Among Primary Care Staff to Achieve Regular Follow-Up of Chronic Patients
  • Shared Decision Making Among Racially and/or Ethnically Diverse Populations in Primary Care: A Scoping Review of Barriers and Facilitators
  • Convenience or Continuity: When Are Patients Willing to Wait to See Their Own Doctor?
Show more Original Research

Similar Articles

Subjects

  • Domains of illness & health:
    • Chronic illness
  • Person groups:
    • Older adults
  • Methods:
    • Quantitative methods
  • Other topics:
    • Communication / decision making
    • Multimorbidity

Keywords

  • adverse drug events
  • older populations
  • primary care
  • patient reported outcomes

Content

  • Current Issue
  • Past Issues
  • Early Access
  • Plain-Language Summaries
  • Multimedia
  • Podcast
  • Articles by Type
  • Articles by Subject
  • Supplements
  • Calls for Papers

Info for

  • Authors
  • Reviewers
  • Job Seekers
  • Media

Engage

  • E-mail Alerts
  • e-Letters (Comments)
  • RSS
  • Journal Club
  • Submit a Manuscript
  • Subscribe
  • Family Medicine Careers

About

  • About Us
  • Editorial Board & Staff
  • Sponsoring Organizations
  • Copyrights & Permissions
  • Contact Us
  • eLetter/Comments Policy

© 2025 Annals of Family Medicine